{"id":"https://openalex.org/W2052397104","doi":"https://doi.org/10.1038/jcbfm.2010.91","title":"Characterization of in vivo Pharmacokinetic Properties of the Dopamine D1 Receptor Agonist DAR-0100A in Nonhuman Primates Using PET with [ 11 C] NNC112 and [ 11 C] Raclopride","display_name":"Characterization of in vivo Pharmacokinetic Properties of the Dopamine D1 Receptor Agonist DAR-0100A in Nonhuman Primates Using PET with [ 11 C] NNC112 and [ 11 C] Raclopride","publication_year":2010,"publication_date":"2010-06-23","ids":{"openalex":"https://openalex.org/W2052397104","doi":"https://doi.org/10.1038/jcbfm.2010.91","mag":"2052397104","pmid":"https://pubmed.ncbi.nlm.nih.gov/20571519","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3049493"},"language":"en","primary_location":{"id":"doi:10.1038/jcbfm.2010.91","doi":"https://doi.org/10.1038/jcbfm.2010.91","is_oa":true,"landing_page_url":"https://doi.org/10.1038/jcbfm.2010.91","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2010.91","source":{"id":"https://openalex.org/S89339265","display_name":"Journal of Cerebral Blood Flow & Metabolism","issn_l":"0271-678X","issn":["0271-678X","1559-7016"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cerebral Blood Flow & Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2010.91","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083715547","display_name":"Mark Slifstein","orcid":"https://orcid.org/0000-0003-2142-6353","observed_orcids":["https://orcid.org/0000-0003-2142-6353"]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark Slifstein","raw_affiliation_strings":["Department of Psychiatry, Columbia University, New York, New York, USA","New York State Psychiatric Institute, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University, New York, New York, USA","institution_ids":["https://openalex.org/I78577930"]},{"raw_affiliation_string":"New York State Psychiatric Institute, New York, New York, USA","institution_ids":["https://openalex.org/I4388891851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025902845","display_name":"Raymond F. Suckow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond F Suckow","raw_affiliation_strings":["New York State Psychiatric Institute, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York State Psychiatric Institute, New York, New York, USA","institution_ids":["https://openalex.org/I4388891851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076865147","display_name":"Jonathan A. Javitch","orcid":"https://orcid.org/0000-0001-7395-2967","observed_orcids":["https://orcid.org/0000-0001-7395-2967"]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan A Javitch","raw_affiliation_strings":["Department of Pharmacology, Columbia University, New York, New York, USA","Department of Psychiatry, Columbia University, New York, New York, USA","New York State Psychiatric Institute, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Columbia University, New York, New York, USA","institution_ids":["https://openalex.org/I78577930"]},{"raw_affiliation_string":"Department of Psychiatry, Columbia University, New York, New York, USA","institution_ids":["https://openalex.org/I78577930"]},{"raw_affiliation_string":"New York State Psychiatric Institute, New York, New York, USA","institution_ids":["https://openalex.org/I4388891851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030014983","display_name":"Thomas B. Cooper","orcid":"https://orcid.org/0000-0001-6048-3479","observed_orcids":["https://orcid.org/0000-0001-6048-3479"]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Cooper","raw_affiliation_strings":["New York State Psychiatric Institute, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York State Psychiatric Institute, New York, New York, USA","institution_ids":["https://openalex.org/I4388891851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075093461","display_name":"Jeffrey Alan Lieberman","orcid":"https://orcid.org/0000-0002-1899-1776","observed_orcids":["https://orcid.org/0000-0002-1899-1776"]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Lieberman","raw_affiliation_strings":["Department of Psychiatry, Columbia University, New York, New York, USA","New York State Psychiatric Institute, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University, New York, New York, USA","institution_ids":["https://openalex.org/I78577930"]},{"raw_affiliation_string":"New York State Psychiatric Institute, New York, New York, USA","institution_ids":["https://openalex.org/I4388891851"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072395467","display_name":"Anissa Abi\u2010Dargham","orcid":"https://orcid.org/0000-0002-5039-5069","observed_orcids":["https://orcid.org/0000-0002-5039-5069"]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anissa Abi-Dargham","raw_affiliation_strings":["Department of Psychiatry, Columbia University, New York, New York, USA","Department of Radiology, Columbia University, New York, New York, USA","New York State Psychiatric Institute, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University, New York, New York, USA","institution_ids":["https://openalex.org/I78577930"]},{"raw_affiliation_string":"Department of Radiology, Columbia University, New York, New York, USA","institution_ids":["https://openalex.org/I78577930"]},{"raw_affiliation_string":"New York State Psychiatric Institute, New York, New York, USA","institution_ids":["https://openalex.org/I4388891851"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5083715547"],"corresponding_institution_ids":["https://openalex.org/I4388891851","https://openalex.org/I78577930"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.9035,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.68788359,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"31","issue":"1","first_page":"293","last_page":"304"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6435999870300293,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6435999870300293,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.30000001192092896,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dihydrexidine","display_name":"dihydrexidine","score":0.9490000009536743},{"id":"https://openalex.org/keywords/dopamine-d1-receptor-agonist","display_name":"dopamine D1 receptor agonist","score":0.9760000109672546},{"id":"https://openalex.org/keywords/receptor-occupancy","display_name":"receptor occupancy","score":0.847000002861023},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7749999761581421},{"id":"https://openalex.org/keywords/11c-raclopride","display_name":"[11C]raclopride","score":0.9950000047683716},{"id":"https://openalex.org/keywords/d2-receptor-binding","display_name":"D2 receptor binding","score":0.8059999942779541},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.7720000147819519},{"id":"https://openalex.org/keywords/cerebral-cortex","display_name":"cerebral cortex","score":0.6959999799728394},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.5210000276565552},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.3019999861717224},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.6349999904632568},{"id":"https://openalex.org/keywords/baboons","display_name":"baboons","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C2781069445","wikidata":"https://www.wikidata.org/wiki/Q7279814","display_name":"Raclopride","level":4,"score":0.9496394395828247},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6704150438308716},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.5730454921722412},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5325272083282471},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4890947937965393},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.4841621518135071},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4808688759803772},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4643939137458801},{"id":"https://openalex.org/C2776743251","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Ventral striatum","level":4,"score":0.44497597217559814},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.43981337547302246},{"id":"https://openalex.org/C2781195155","wikidata":"https://www.wikidata.org/wiki/Q18680","display_name":"Prefrontal cortex","level":3,"score":0.4386330246925354},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.4349689185619354},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.4113267660140991},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36536070704460144},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.33914482593536377},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3192870020866394},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2612186670303345},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2599804997444153},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23738685250282288},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007091","descriptor_name":"Image Processing, Computer-Assisted","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010617","descriptor_name":"Phenanthridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D017447","descriptor_name":"Receptors, Dopamine D1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020891","descriptor_name":"Raclopride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D048530","descriptor_name":"Papio anubis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/jcbfm.2010.91","doi":"https://doi.org/10.1038/jcbfm.2010.91","is_oa":true,"landing_page_url":"https://doi.org/10.1038/jcbfm.2010.91","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2010.91","source":{"id":"https://openalex.org/S89339265","display_name":"Journal of Cerebral Blood Flow & Metabolism","issn_l":"0271-678X","issn":["0271-678X","1559-7016"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cerebral Blood Flow & Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2255264","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3049493","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3049493","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3049493","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Cereb Blood Flow Metab","raw_type":"Text"},{"id":"pmid:20571519","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20571519","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/jcbfm.2010.91","doi":"https://doi.org/10.1038/jcbfm.2010.91","is_oa":true,"landing_page_url":"https://doi.org/10.1038/jcbfm.2010.91","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2010.91","source":{"id":"https://openalex.org/S89339265","display_name":"Journal of Cerebral Blood Flow & Metabolism","issn_l":"0271-678X","issn":["0271-678X","1559-7016"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cerebral Blood Flow & Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1743979179","display_name":"Pharmacologic and Clinical Testing of a D1 Agonist for Neuropsychiatric Disorders","funder_award_id":"U01MH076544","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G3162827656","display_name":"Molecular determinants for the action of psychostimulants","funder_award_id":"K05DA022413","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000894949","display_name":"Structure and Function of Dopamine Receptors","funder_award_id":"R01MH054137","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2052397104.pdf"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1578186125","https://openalex.org/W1957898531","https://openalex.org/W1963763914","https://openalex.org/W1967625698","https://openalex.org/W1973371295","https://openalex.org/W1973611024","https://openalex.org/W1977138162","https://openalex.org/W1979897535","https://openalex.org/W1992381398","https://openalex.org/W1995778321","https://openalex.org/W1999754119","https://openalex.org/W2000124302","https://openalex.org/W2017836845","https://openalex.org/W2033524647","https://openalex.org/W2048865270","https://openalex.org/W2054230322","https://openalex.org/W2057684612","https://openalex.org/W2058089380","https://openalex.org/W2061833498","https://openalex.org/W2064746296","https://openalex.org/W2066640528","https://openalex.org/W2077959816","https://openalex.org/W2086233186","https://openalex.org/W2109307487","https://openalex.org/W2111598084","https://openalex.org/W2112278807","https://openalex.org/W2116649573","https://openalex.org/W2116888010","https://openalex.org/W2117671988","https://openalex.org/W2136672278","https://openalex.org/W2138021751","https://openalex.org/W2150471590","https://openalex.org/W2154236181","https://openalex.org/W2164880864","https://openalex.org/W2165545769","https://openalex.org/W2167264579","https://openalex.org/W2170019144","https://openalex.org/W4253820701"],"related_works":["https://openalex.org/W1968176029","https://openalex.org/W2019648896","https://openalex.org/W2044621390","https://openalex.org/W1555473846","https://openalex.org/W2066735646","https://openalex.org/W1936296662","https://openalex.org/W1597234364","https://openalex.org/W4231547797","https://openalex.org/W2050427408","https://openalex.org/W2135747349"],"abstract_inverted_index":{"DAR-0100A,":[0],"the":[1,26,89,109,113,126,143,146,191],"active":[2],"enantiomer":[3],"of":[4,16,22,67,82,101,121,153,182,196],"dihydrexidine,":[5],"is":[6,128,190],"a":[7,197,201],"potent":[8],"dopamine":[9],"D1":[10,32,203],"agonist":[11,204],"under":[12],"investigation":[13],"for":[14,29],"treatment":[15],"cognitive":[17],"impairment":[18],"and":[19,45,62,78,91,103,180],"negative":[20],"symptoms":[21],"schizophrenia.":[23],"We":[24],"measured":[25],"dose-occupancy":[27],"relationship":[28,95],"DAR-0100A":[30,102,154,183],"at":[31,60,76,163],"receptors":[33],"using":[34],"positron":[35],"emission":[36],"tomography":[37],"(PET)":[38],"imaging":[39],"in":[40,88,108,112,125,205],"baboons":[41,54,70],"with":[42,50,57,73,116,176,194],"[(11)C]":[43,51,58,74,122,156,177],"NNC112":[44,59,123,178],"its":[46],"binding":[47,181],"to":[48,130,138,142,166,169,184],"D2":[49,185],"raclopride.":[52],"Two":[53,69],"were":[55,71],"scanned":[56,72],"baseline":[61,77],"after":[63,79],"three":[64],"different":[65],"doses":[66,164],"DAR-0100A.":[68,83],"raclopride":[75,157],"one":[80],"dose":[81],"Occupancy":[84],"(\u0394BP(ND))":[85],"was":[86,96,106,149],"computed":[87],"striatum":[90,110],"cortex.":[92],"A":[93],"clear":[94],"observed":[97],"between":[98],"plasma":[99],"concentration":[100],"\u0394BP(ND).":[104],"\u0394BP(ND)":[105],"larger":[107],"than":[111],"cortex,":[114],"consistent":[115],"reports":[117],"showing":[118],"that":[119,162],"25%":[120],"BP(ND)":[124],"cortex":[127],"attributed":[129],"5-HT(2A).":[131],"Plasma":[132],"EC(50)":[133],"estimates":[134],"ranged":[135],"from":[136],"150":[137],"550":[139],"ng/mL":[140],"according":[141],"constraints":[144],"on":[145,155],"model.":[147],"There":[148],"no":[150],"detectable":[151,175],"effect":[152],"BP(ND).":[158],"These":[159],"data":[160],"suggest":[161],"likely":[165],"be":[167,174,187],"administered":[168],"patients,":[170],"occupancy":[171,199],"will":[172,186],"not":[173],"PET":[179,195],"negligible.":[188],"This":[189],"first":[192],"demonstration":[193],"significant":[198],"by":[200],"full":[202],"vivo.":[206]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}